polycystic ovary syndrome
Conditions
Interventions
1:ZiYu Prescription+dydrogesterone
2:placebo+dydrogesterone
Sponsors
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) It meets the diagnostic criteria of Western medicine for polycystic ovary syndrome and the diagnostic criteria of traditional Chinese medicine for renal deficiency; (2) Between the ages of 18 and 40. (3) Have not taken any drugs that affect menstruation (such as contraceptives, hormones or other drugs that affect insulin, blood glucose, sex hormones and lipid metabolism) within 3 months and have not used relevant treatment methods, and have no record of induced abortion; (4) Gynecological examination and auxiliary examination: there are no organic lesions of internal and external genitalia, and there are no other primary diseases; (5) Sign the patient's informed consent form.
Exclusion criteria
Exclusion criteria: (1) The presence of congenital deficiencies in the patient's reproductive system cannot meet the needs of this study. (2) The patient has a congenital inherited mental illness. (3) The patient's liver, heart, kidney, hematopoietic system and other human organ functions are failed. (4) The patient has a special physique and has a history of serious allergies to the drug. (5) Patients who cannot be performed according to this study protocol. (6) Patients with other diseases need to undergo other aspects of treatment, and patients who may have an impact on this study. (7) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Days of menstrual cycle; | — |
Secondary
| Measure | Time frame |
|---|---|
| FINS;E2;FPG;AMH;FSH;TC;LDL;T;LH;TG; | — |
Countries
China
Contacts
Public ContactBingYi Yang
Outcome results
None listed